Insider trades
Almstead Neil Gregory, Chief Officer of PTC Therapeutics PTCT, has filed 0 purchases and 82 sales on the open market. Over the past 12 months that comes to a net sale of $21.7M. The latest trade was on 06/26.
Almstead Neil Gregory
Chief Technical Ops Officer
- Company
- PTC Therapeutics PTCT
- First filing
- 23/01/09
- Trades
- 141 trades
- Buys / sales
- 0 / 82
- 12-month net buying
- −$21.7M
- Last trade
- 06/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTCT | Open-market sale10b5-1 plan | 06/26 | 06/30 | 8,130 sh2 trades | $85.26avg. | $693,151.44 | −11.9% |
PTCT | Open-market sale10b5-1 plan | 06/24–06/25 | 06/26 | 26,283 sh7 trades | $85.78avg. | $2,254,463.35 | −30.4% |
PTCT | Open-market sale10b5-1 plan | 06/22 | 06/24 | 23,749 sh2 trades | $80.90avg. | $1,921,378.29 | −28.3% |
PTCT | Open-market sale10b5-1 plan | 04/01 | 04/03 | 52,003 sh3 trades | $69.04avg. | $3,590,242.77 | −46.4% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 03/05 | 03/09 | 3,989 sh | $63.38 | $252,822.82 | −59.3% |
PTCT | Open-market sale10b5-1 plan | 02/18 | 02/20 | 3,121 sh2 trades | $69.36avg. | $216,472.56 | No record |
PTCT | Open-market sale10b5-1 plan | 01/08 | 01/12 | 940 sh2 trades | $76.45avg. | $71,863 | No record |
PTCT | Open-market sale10b5-1 plan | 01/06–01/07 | 01/08 | 2,411 sh4 trades | $77.19avg. | $186,097.79 | No record |
PTCT | Open-market sale10b5-1 plan | 25/11/24–25/11/25 | 25/11/26 | 107,500 sh24 trades | $82.36avg. | $8,853,962.61 | −51.7% |
PTCT | Open-market sale10b5-1 plan | 25/10/03 | 25/10/07 | 55,000 sh6 trades | $66.05avg. | $3,632,976.72 | −35.3% |
PTCT | Open-market sale10b5-1 plan | 25/02/19–25/02/20 | 25/02/21 | 2,946 sh4 trades | $50.11avg. | $147,626.84 | No record |
PTCT | Open-market sale10b5-1 plan | 25/01/07–25/01/08 | 25/01/10 | 2,979 sh4 trades | $44.87avg. | $133,674.3 | No record |
PTCT | Open-market sale10b5-1 plan | 24/12/02 | 24/12/04 | 71,610 sh6 trades | $52.06avg. | $3,727,957.62 | No record |
PTCT | Open-market sale10b5-1 plan | 24/01/30 | 24/02/01 | 646 sh2 trades | $27.25avg. | $17,603.5 | No record |
PTCT | Open-market sale10b5-1 plan | 24/01/08–24/01/09 | 24/01/10 | 2,910 sh4 trades | $28.85avg. | $83,942.17 | No record |
PTCT | Open-market sale | 23/01/31 | 23/02/02 | 658 sh2 trades | $45.63avg. | $30,024.54 | No record |
PTC TherapeuticsPTCT | Open-market sale | 23/01/24 | 23/01/26 | 44 sh | $47.45 | $2,087.8 | −1.3% |
PTCT | Open-market sale | 23/01/10–23/01/11 | 23/01/12 | 910 sh4 trades | $43.57avg. | $39,652.6 | No record |
PTCT | Open-market sale | 23/01/09 | 23/01/11 | 759 sh2 trades | $41.66avg. | $31,619.94 | No record |